1 |
Factor IX Complex (Human)
| 1件: Prothrombin Complex Concentrate Prothrombin Complex Concentrate | - | - | - | 1件: 288 288 |
2 |
Factor XIII (human)
| 1件: Factor XIII Factor XIII | - | - | - | 3件: 51 51, 97, 288 |
3 |
Famciclovir
| 1件: Famciclovir Famciclovir | 1件: D00317
D00317
| - | - | 1件: 13 13 |
4 |
Famotidine
| 2件: FAMOTIDINA FAMOTIDINA; Famotidine | 1件: D00318
D00318
| 1件: HRH2 HRH2 💬 | 3件: Calcium signaling pathway Calcium signaling pathway, Gastric acid secretion, Neuroactive ligand-receptor interaction 💬 | 7件: 6 6, 46, 61, 86, 98, 107, 300 |
5 |
Fasudil
| 1件: Fasudil Fasudil | 1件: D07941
D07941
| 2件: ROCK1 ROCK1, ROCK2 💬 | 23件: Axon guidance Axon guidance, Chemokine signaling pathway, Focal adhesion, Human cytomegalovirus infection, Leukocyte transendothelial migration, Lipid and atherosclerosis, MicroRNAs in cancer, Oxytocin signaling pathway, Pathogenic Escherichia coli infection, Pathways in cancer, Platelet activation, Proteoglycans in cancer, Regulation of actin cytoskeleton, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, TGF-beta signaling pathway, Tight junction, Vascular smooth muscle contraction, Wnt signaling pathway, Yersinia infection, cAMP signaling pathway, cGMP-PKG signaling pathway 💬 | 4件: 2 2, 5, 7, 51 |
6 |
Febuxostat
| 1件: Febuxostat Febuxostat | 1件: D01206
D01206
| 1件: XDH XDH 💬 | 5件: Caffeine metabolism Caffeine metabolism, Drug metabolism - other enzymes, Metabolic pathways, Peroxisome, Purine metabolism 💬 | 3件: 2 2, 6, 13 |
7 |
Felzartamab
| 1件: Felzartamab Felzartamab | - | - | - | 1件: 66 66 |
8 |
Fenamole
| 0件: | 1件: D04139
D04139
| - | - | 3件: 6 6, 13, 160 |
9 |
Fenebrutinib
| 1件: FENEBRUTINIB FENEBRUTINIB | 1件: D11457
D11457
| 1件: BTK BTK 💬 | 7件: B cell receptor signaling pathway B cell receptor signaling pathway, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, NF-kappa B signaling pathway, Osteoclast differentiation, Platelet activation, Primary immunodeficiency 💬 | 1件: 13 13 |
10 |
Fenfluramine
| 2件: Fenfluramina Fenfluramina; Fenfluramine | 1件: D07945
D07945
| 4件: HTR2A HTR2A, HTR2B, HTR2C, SLC6A4 💬 | 6件: Calcium signaling pathway Calcium signaling pathway, Gap junction, Inflammatory mediator regulation of TRP channels, Neuroactive ligand-receptor interaction, Serotonergic synapse, Synaptic vesicle cycle 💬 | 4件: 140 140, 144, 145, 149 |
11 |
Fenofibrate
| 1件: Fenofibrate Fenofibrate | 1件: D00565
D00565
| 1件: PPARA PPARA 💬 | 10件: Adipocytokine signaling pathway Adipocytokine signaling pathway, Alcoholic liver disease, Chemical carcinogenesis - receptor activation, Diabetic cardiomyopathy, Glucagon signaling pathway, Hepatitis C, Insulin resistance, Non-alcoholic fatty liver disease, PPAR signaling pathway, cAMP signaling pathway 💬 | 5件: 8 8, 79, 93, 94, 265 |
12 |
Fenretinide
| 1件: Fenretinide Fenretinide | 1件: D04162
D04162
| 2件: RARA RARA, RARB 💬 | 8件: Acute myeloid leukemia Acute myeloid leukemia, Estrogen signaling pathway, Gastric cancer, Non-small cell lung cancer, Pathways in cancer, Small cell lung cancer, Th17 cell differentiation, Transcriptional misregulation in cancer 💬 | 1件: 299 299 |
13 |
Fentanyl
| 1件: Fentanyl Fentanyl | 2件: D00320
D00320
,
D01399
| 1件: OPRM1 OPRM1 💬 | 3件: Estrogen signaling pathway Estrogen signaling pathway, Morphine addiction, Neuroactive ligand-receptor interaction 💬 | 4件: 46 46, 70, 215, 231 |
14 |
Ferric carboxymaltose
| 1件: FERRIC CARBOXYMALTOSE FERRIC CARBOXYMALTOSE | 1件: D08920
D08920
| - | - | 4件: 86 86, 96, 97, 299 |
15 |
Ferric maltol
| 1件: Ferric Maltol Ferric Maltol | 1件: D10833
D10833
| - | - | 1件: 96 96 |
16 |
Ferric oxide
| 1件: Iron oxide Iron oxide | 1件: D04168
D04168
| - | - | 1件: 13 13 |
17 |
Ferric pyrophosphate citrate
| 0件: | 1件: D10933
D10933
| - | - | 1件: 13 13 |
18 |
Ferric sulfate
| 1件: Stasis Stasis | 1件: D08922
D08922
| - | - | 2件: 66 66, 97 |
19 |
Ferrous sulfate anhydrous
| 0件: | - | - | - | 1件: 46 46 |
20 |
Ferulic acid
| 1件: Ferulic acid Ferulic acid | - | - | - | 1件: 127 127 |
21 |
Ferumoxytol
| 2件: Feraheme Feraheme; Ferumoxytol | 1件: D04177
D04177
| - | - | 1件: 13 13 |
22 |
Fesoterodine
| 1件: Fesoterodine Fesoterodine | 1件: D07226
D07226
| 2件: CHRM2 CHRM2, CHRM3 💬 | 13件: Alzheimer disease Alzheimer disease, Calcium signaling pathway, Cholinergic synapse, Gastric acid secretion, Insulin secretion, Neuroactive ligand-receptor interaction, PI3K-Akt signaling pathway, Pancreatic secretion, Pathways of neurodegeneration - multiple diseases, Regulation of actin cytoskeleton, Salivary secretion, Taste transduction, cAMP signaling pathway 💬 | 1件: 6 6 |
23 |
Fexinidazole
| 1件: Fexinidazole Fexinidazole | 1件: D11252
D11252
| - | - | 1件: 65 65 |
24 |
Fexofenadine
| 1件: Fexofenadine Fexofenadine | 2件: D00671
D00671
,
D07958
| 1件: HRH1 HRH1 💬 | 3件: Calcium signaling pathway Calcium signaling pathway, Inflammatory mediator regulation of TRP channels, Neuroactive ligand-receptor interaction 💬 | 2件: 13 13, 46 |
25 |
Fibrin
| 1件: Fibrin Fibrin | - | - | - | 1件: 96 96 |
26 |
Fibrinogen human
| 3件: Fibrinogen Fibrinogen; Fibrinogen concentrate; HUMAN FIBRINOGEN | - | - | - | 3件: 14 14, 65, 288 |
27 |
Fig
| 1件: Fig Fig | - | - | - | 1件: 2 2 |
28 |
Filgotinib
| 2件: FILGOTINIB FILGOTINIB; Jyseleca | 1件: D10871
D10871
| 1件: JAK1 JAK1 💬 | 27件: Coronavirus disease - COVID-19 Coronavirus disease - COVID-19, EGFR tyrosine kinase inhibitor resistance, Epstein-Barr virus infection, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Measles, NOD-like receptor signaling pathway, Necroptosis, Osteoclast differentiation, PD-L1 expression and PD-1 checkpoint pathway in cancer, PI3K-Akt signaling pathway, Pancreatic cancer, Pathways in cancer, Signaling pathways regulating pluripotency of stem cells, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toxoplasmosis, Tuberculosis, Viral carcinogenesis 💬 | 6件: 46 46, 53, 96, 97, 222, 271 |
29 |
Filgrastim
| 7件: Filgrastim Filgrastim; Filgrastim Hexal; G-CSF; Granulocyte Colony Stimulating Factor; NEUPOGEN; TEVAGRASTIM; ZARZIO | 1件: D03235
D03235
| 1件: CSF3R CSF3R 💬 | 5件: Cytokine-cytokine receptor interaction Cytokine-cytokine receptor interaction, Hematopoietic cell lineage, JAK-STAT signaling pathway, PI3K-Akt signaling pathway, Pathways in cancer 💬 | 34件: 2 2, 6, 11, 13, 16, 25, 26, 28, 34, 35, 36, 38, 40, 41, 42, 45, 46, 47, 49, 51, 57, 60, 62, 65, 85, 96, 113, 164, 256, 283, 284, 285, 296, 331 |
30 |
Finasteride
| 1件: Finasteride Finasteride | 1件: D00321
D00321
| 1件: SRD5A2 SRD5A2 💬 | 3件: Metabolic pathways Metabolic pathways, Prostate cancer, Steroid hormone biosynthesis 💬 | 1件: 6 6 |
31 |
Fingolimod
| 2件: Fingolimod Fingolimod; Gilenya | 1件: D10001
D10001
| 1件: S1PR1 S1PR1 💬 | 3件: FoxO signaling pathway FoxO signaling pathway, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway 💬 | 3件: 13 13, 14, 156 |
32 |
Fipamezole
| 1件: Fipamezole Fipamezole | - | - | - | 2件: 6 6, 17 |
33 |
Firategrast
| 1件: Firategrast Firategrast | 1件: D06590
D06590
| 1件: ITGA4 ITGA4 💬 | 14件: Arrhythmogenic right ventricular cardiomyopathy Arrhythmogenic right ventricular cardiomyopathy, Cell adhesion molecules, Dilated cardiomyopathy, ECM-receptor interaction, Focal adhesion, Hematopoietic cell lineage, Human papillomavirus infection, Hypertrophic cardiomyopathy, Intestinal immune network for IgA production, Leishmaniasis, Leukocyte transendothelial migration, PI3K-Akt signaling pathway, Regulation of actin cytoskeleton, Yersinia infection 💬 | 1件: 13 13 |
34 |
Fish oil
| 4件: Fish Oil Fish Oil; Omegaven; Smofkabiven; SMOFLipid | - | - | - | 7件: 13 13, 46, 49, 66, 96, 260, 299 |
35 |
Flavoxate
| 1件: Flavoxate Flavoxate | 2件: D00718
D00718
,
D07961
| 16件: PDE10A PDE10A, PDE11A, PDE1A, PDE1B, PDE1C, PDE2A, PDE3A, PDE3B, PDE4A, PDE4B, PDE4C, PDE4D, PDE7A, PDE7B, PDE8A, PDE8B 💬 | 18件: Aldosterone synthesis and secretion Aldosterone synthesis and secretion, Apelin signaling pathway, Calcium signaling pathway, Cortisol synthesis and secretion, Cushing syndrome, Glucagon signaling pathway, Insulin signaling pathway, Metabolic pathways, Morphine addiction, Olfactory transduction, Parathyroid hormone synthesis, secretion and action, Progesterone-mediated oocyte maturation, Purine metabolism, Regulation of lipolysis in adipocytes, Renin secretion, Taste transduction, cAMP signaling pathway, cGMP-PKG signaling pathway 💬 | 1件: 226 226 |
36 |
Flax seed
| 1件: Flaxseed Flaxseed | - | - | - | 2件: 97 97, 299 |
37 |
Flecainide
| 3件: Flecainide Flecainide; FLECAINIDE ACETATE; Flecainidum | 2件: D00638
D00638
,
D07962
| 5件: SCN1A SCN1A, SCN2A, SCN3A, SCN5A, SCN9A 💬 | 3件: Adrenergic signaling in cardiomyocytes Adrenergic signaling in cardiomyocytes, Dopaminergic synapse, Taste transduction 💬 | 1件: 6 6 |
38 |
Fletikumab
| 1件: Anti-IL-20 Anti-IL-20 | 1件: D11756
D11756
| 1件: IL20 IL20 💬 | 3件: Cytokine-cytokine receptor interaction Cytokine-cytokine receptor interaction, JAK-STAT signaling pathway, Viral protein interaction with cytokine and cytokine receptor 💬 | 1件: 46 46 |
39 |
Florasulam
| 1件: PRIMUS PRIMUS | - | - | - | 1件: 46 46 |
40 |
Florbenazine F-18
| 1件: 18F-AV-133 18F-AV-133 | - | - | - | 1件: 6 6 |
41 |
Florbetaben (18F)
| 2件: FLORBETABEN (18F) FLORBETABEN (18F); Neuraceq | - | - | - | 1件: 6 6 |
42 |
Florbetapir (18F)
| 2件: Amyvid Amyvid; Florbetapir (18F) | - | - | - | 2件: 13 13, 127 |
43 |
Florilglutamic acid F-18
| 1件: 18F-FSPG 18F-FSPG | - | - | - | 1件: 84 84 |
44 |
Flortaucipir
| 1件: Flortaucipir Flortaucipir | 1件: D11210
D11210
| 1件: MAPT MAPT 💬 | 4件: Alzheimer disease Alzheimer disease, MAPK signaling pathway, Parkinson disease, Pathways of neurodegeneration - multiple diseases 💬 | 3件: 5 5, 7, 127 |
45 |
Flucloxacillin
| 1件: FLUCLOXACILLIN FLUCLOXACILLIN | 3件: D01249
D01249
,
D04196
,
D07965
| - | - | 1件: 299 299 |
46 |
Fluconazole
| 2件: Diflucan Diflucan; FLUCONAZOLE | 2件: D00322
D00322
,
D01429
| - | - | 2件: 96 96, 225 |
47 |
Fludarabine
| 4件: FLUDARA FLUDARA; Fludarabina; Fludarabine; Fludarabine Phosphate | 2件: D01907
D01907
,
D07966
| 1件: RRM1 RRM1 💬 | 5件: Drug metabolism - other enzymes Drug metabolism - other enzymes, Glutathione metabolism, Metabolic pathways, Purine metabolism, Pyrimidine metabolism 💬 | 19件: 13 13, 19, 28, 36, 46, 49, 51, 60, 61, 62, 65, 85, 96, 164, 283, 284, 285, 286, 326 |
48 |
Fludeoxyglucose
| 1件: Fludeoxyglucose Fludeoxyglucose | 1件: D01843
D01843
| - | - | 4件: 34 34, 84, 85, 88 |
49 |
Fludeoxyglucose (18F)
| 3件: 18F-FDG 18F-FDG; Fludeoxyglucose; Fludeoxyglucose F 18 | - | - | - | 14件: 5 5, 6, 7, 8, 13, 34, 41, 46, 53, 84, 85, 96, 127, 300 |
50 |
Fludrocortisone
| 1件: Fludrocortisone Fludrocortisone | 2件: D00986
D00986
,
D07967
| 1件: NR3C2 NR3C2 💬 | 1件: Aldosterone-regulated sodium reabsorption Aldosterone-regulated sodium reabsorption 💬 | 3件: 6 6, 17, 81 |
51 |
Flumazenil
| 1件: Flumazenil Flumazenil | 1件: D00697
D00697
| 16件: GABRA1 GABRA1, GABRA2, GABRA3, GABRA4, GABRA5, GABRA6, GABRB1, GABRB2, GABRB3, GABRD, GABRE, GABRG1, GABRG2, GABRG3, GABRP, GABRQ 💬 | 7件: GABAergic synapse GABAergic synapse, Morphine addiction, Neuroactive ligand-receptor interaction, Nicotine addiction, Retrograde endocannabinoid signaling, Serotonergic synapse, Taste transduction 💬 | 5件: 6 6, 13, 17, 18, 206 |
52 |
Flunarizine
| 0件: | 2件: D01303
D01303
,
D07971
| 3件: CACNA1G CACNA1G, CACNA1H, CACNA1I 💬 | 8件: Aldosterone synthesis and secretion Aldosterone synthesis and secretion, Calcium signaling pathway, Circadian entrainment, Cortisol synthesis and secretion, Cushing syndrome, GnRH secretion, MAPK signaling pathway, Type II diabetes mellitus 💬 | 4件: 58 58, 86, 149, 215 |
53 |
Fluocinolone
| 1件: Fluocinolone Fluocinolone | - | - | - | 1件: 90 90 |
54 |
Fluocinolone acetonide
| 2件: Fluocinolone Acetonide Fluocinolone Acetonide; Iluvien | 1件: D01825
D01825
| 1件: NR3C1 NR3C1 💬 | 1件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | 1件: 90 90 |
55 |
Fluorescein
| 1件: Fluorescein Fluorescein | 2件: D01261
D01261
,
D02024
| - | - | 3件: 19 19, 22, 97 |
56 |
Fluorine F-18
| 1件: FLUORINE-18 FLUORINE-18 | 1件: D05860
D05860
| - | - | 1件: 41 41 |
57 |
Fluoxetine
| 5件: Fluoxetin Fluoxetin; Fluoxetine; FLUOXETINE HYDROCHLORIDE; Fluoxétine; PROZAC | 2件: D00326
D00326
,
D00823
| 1件: SLC6A4 SLC6A4 💬 | 2件: Serotonergic synapse Serotonergic synapse, Synaptic vesicle cycle 💬 | 6件: 13 13, 17, 78, 86, 179, 206 |
58 |
Flupentixol
| 1件: Flupentixol Flupentixol | 1件: D01044
D01044
| 2件: DRD1 DRD1, DRD2 💬 | 11件: Alcoholism Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬 | 1件: 97 97 |
59 |
Flupirtine
| 1件: Flupirtine Flupirtine | 1件: D07978
D07978
| - | - | 1件: 13 13 |
60 |
Flurbiprofen
| 1件: Flurbiprofen Flurbiprofen | 3件: D00330
D00330
,
D01475
,
D02290
| 2件: PTGS1 PTGS1, PTGS2 💬 | 23件: Alzheimer disease Alzheimer disease, Arachidonic acid metabolism, C-type lectin receptor signaling pathway, Chemical carcinogenesis - DNA adducts, Human cytomegalovirus infection, Human papillomavirus infection, IL-17 signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Metabolic pathways, MicroRNAs in cancer, NF-kappa B signaling pathway, Ovarian steroidogenesis, Oxytocin signaling pathway, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Platelet activation, Regulation of lipolysis in adipocytes, Retrograde endocannabinoid signaling, Serotonergic synapse, Small cell lung cancer, TNF signaling pathway, VEGF signaling pathway 💬 | 3件: 13 13, 21, 46 |
61 |
Flutamide
| 1件: Flutamide Flutamide | 1件: D00586
D00586
| 1件: AR AR 💬 | 4件: Chemical carcinogenesis - receptor activation Chemical carcinogenesis - receptor activation, Oocyte meiosis, Pathways in cancer, Prostate cancer 💬 | 1件: 81 81 |
62 |
Flutemetamol
| 1件: Flutemetamol Flutemetamol | - | - | - | 5件: 5 5, 6, 7, 17, 127 |
63 |
Flutemetamol (18F)
| 3件: Flutemetamol Flutemetamol; Flutemetamol F18; Vizamyl | - | - | - | 5件: 5 5, 6, 7, 17, 127 |
64 |
Fluticasone
| 1件: Fluticasone Fluticasone | 1件: D07981
D07981
| 1件: NR3C1 NR3C1 💬 | 1件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | 3件: 98 98, 228, 299 |
65 |
Fluticasone propionate
| 3件: Flovent Flovent; Fluticasone; Fluticasone propionate | 1件: D01708
D01708
| 1件: NR3C1 NR3C1 💬 | 1件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | 2件: 98 98, 228 |
66 |
Flutriciclamide F-18
| 1件: 18F-GE-180 18F-GE-180 | - | - | - | 1件: 46 46 |
67 |
Fluvastatin
| 1件: Fluvastatin Fluvastatin | 2件: D00892
D00892
,
D07983
| 1件: HMGCR HMGCR 💬 | 4件: AMPK signaling pathway AMPK signaling pathway, Bile secretion, Metabolic pathways, Terpenoid backbone biosynthesis 💬 | 3件: 79 79, 218, 222 |
68 |
Folic acid
| 5件: Acide folique Acide folique; Folate; Folic Acid; Multivitamin; NICOTINAMIDE | 1件: D00070
D00070
| - | - | 6件: 6 6, 13, 41, 46, 49, 84 |
69 |
Foliglurax
| 1件: Foliglurax Foliglurax | - | - | - | 1件: 6 6 |
70 |
Fomepizole
| 1件: 4-Methylpyrazole 4-Methylpyrazole | 1件: D00707
D00707
| 3件: ADH1A ADH1A, ADH1B, ADH1C 💬 | 9件: Alcoholic liver disease Alcoholic liver disease, Drug metabolism - cytochrome P450, Fatty acid degradation, Glycolysis / Gluconeogenesis, Metabolic pathways, Metabolism of xenobiotics by cytochrome P450, Pyruvate metabolism, Retinol metabolism, Tyrosine metabolism 💬 | 1件: 301 301 |
71 |
Fontolizumab
| 1件: Fontolizumab Fontolizumab | 1件: D04242
D04242
| 1件: IFNG IFNG 💬 | 32件: African trypanosomiasis African trypanosomiasis, Allograft rejection, Amoebiasis, Antigen processing and presentation, Chagas disease, Cytokine-cytokine receptor interaction, Fluid shear stress and atherosclerosis, Graft-versus-host disease, HIF-1 signaling pathway, Hepatitis C, Herpes simplex virus 1 infection, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, JAK-STAT signaling pathway, Leishmaniasis, Malaria, Natural killer cell mediated cytotoxicity, Necroptosis, Osteoclast differentiation, PD-L1 expression and PD-1 checkpoint pathway in cancer, Pathways in cancer, Proteasome, Rheumatoid arthritis, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus 💬 | 1件: 46 46 |
72 |
Foralumab
| 1件: Foralumab Foralumab | - | - | - | 2件: 13 13, 96 |
73 |
Forigerimod
| 1件: Forigerimod Forigerimod | 1件: D09904
D09904
| - | - | 1件: 49 49 |
74 |
Formaldehyde
| 1件: Formalin Formalin | 1件: D00017
D00017
| - | - | 1件: 84 84 |
75 |
Formoterol
| 2件: Formoterol Formoterol; Symbicort | 3件: D01373
D01373
,
D05277
,
D07990
| 1件: ADRB2 ADRB2 💬 | 9件: Adrenergic signaling in cardiomyocytes Adrenergic signaling in cardiomyocytes, Calcium signaling pathway, Chemical carcinogenesis - receptor activation, Neuroactive ligand-receptor interaction, Regulation of lipolysis in adipocytes, Renin secretion, Salivary secretion, cAMP signaling pathway, cGMP-PKG signaling pathway 💬 | 3件: 85 85, 228, 299 |
76 |
Foscarbidopa
| 1件: Foscarbidopa Foscarbidopa | 1件: D12057
D12057
| - | - | 1件: 6 6 |
77 |
Foscarnet
| 2件: Foscarnet Foscarnet; Foscarnet sodium | 2件: D00579
D00579
,
D02267
| - | - | 2件: 28 28, 60 |
78 |
Fosfomycin
| 1件: Fosfomycin Fosfomycin | 4件: D00925
D00925
,
D02187
,
D02188
,
D04253
| - | - | 4件: 63 63, 96, 97, 222 |
79 |
Foslevodopa
| 1件: Foslevodopa Foslevodopa | 1件: D11839
D11839
| 5件: DRD1 DRD1, DRD2, DRD3, DRD4, DRD5 💬 | 11件: Alcoholism Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬 | 1件: 6 6 |
80 |
Fospropofol
| 1件: Fospropofol Fospropofol | - | - | - | 1件: 226 226 |
81 |
Fostamatinib
| 1件: Fostamatinib Fostamatinib | 1件: D09347
D09347
| 1件: SYK SYK 💬 | 17件: B cell receptor signaling pathway B cell receptor signaling pathway, C-type lectin receptor signaling pathway, Coronavirus disease - COVID-19, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fc gamma R-mediated phagocytosis, Herpes simplex virus 1 infection, Kaposi sarcoma-associated herpesvirus infection, NF-kappa B signaling pathway, Natural killer cell mediated cytotoxicity, Neutrophil extracellular trap formation, Osteoclast differentiation, PI3K-Akt signaling pathway, Phospholipase D signaling pathway, Platelet activation, Tuberculosis, Viral carcinogenesis 💬 | 4件: 46 46, 49, 61, 66 |
82 |
Fremanezumab
| 1件: Fremanezumab Fremanezumab | 1件: D11055
D11055
| 1件: CALCA CALCA 💬 | 2件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction, Vascular smooth muscle contraction 💬 | 2件: 124 124, 226 |
83 |
Fresolimumab
| 2件: Fresolimumab Fresolimumab; GC1008 | 1件: D09620
D09620
| 3件: TGFB1 TGFB1, TGFB2, TGFB3 💬 | 35件: AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Amoebiasis, Cell cycle, Cellular senescence, Chagas disease, Chronic myeloid leukemia, Colorectal cancer, Cytokine-cytokine receptor interaction, Diabetic cardiomyopathy, Dilated cardiomyopathy, FoxO signaling pathway, Gastric cancer, Hepatitis B, Hepatocellular carcinoma, Hippo signaling pathway, Human T-cell leukemia virus 1 infection, Hypertrophic cardiomyopathy, Inflammatory bowel disease, Intestinal immune network for IgA production, Leishmaniasis, MAPK signaling pathway, Malaria, MicroRNAs in cancer, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pancreatic cancer, Pathways in cancer, Proteoglycans in cancer, Relaxin signaling pathway, Renal cell carcinoma, Rheumatoid arthritis, TGF-beta signaling pathway, Th17 cell differentiation, Toxoplasmosis, Tuberculosis 💬 | 4件: 51 51, 85, 222, 274 |
84 |
Fucose
| 2件: Fucose Fucose; L-fucose | - | - | - | 1件: 65 65 |
85 |
Fulvestrant
| 2件: Faslodex Faslodex; Fulvestrant | 1件: D01161
D01161
| 2件: ESR1 ESR1, ESR2 💬 | 10件: Breast cancer Breast cancer, Chemical carcinogenesis - receptor activation, Endocrine and other factor-regulated calcium reabsorption, Endocrine resistance, Estrogen signaling pathway, GnRH secretion, Pathways in cancer, Prolactin signaling pathway, Proteoglycans in cancer, Thyroid hormone signaling pathway 💬 | 2件: 49 49, 86 |
86 |
Fumaric acid
| 1件: Fumaric acid Fumaric acid | 1件: D02308
D02308
| - | - | 2件: 13 13, 49 |
87 |
Furosemide
| 2件: Furosemide Furosemide; Furosemide Injection | 1件: D00331
D00331
| 1件: SLC12A2 SLC12A2 💬 | 3件: Pancreatic secretion Pancreatic secretion, Salivary secretion, Vibrio cholerae infection 💬 | 1件: 6 6 |
88 |
Fusidic acid
| 2件: Fucidin Fucidin; FUSIDIC ACID | 1件: D04281
D04281
| - | - | 1件: 299 299 |
89 |
Fx-1006A
| 1件: Fx-1006A Fx-1006A | - | - | - | 1件: 28 28 |